Neogenomics Inc
Research Neogenomics Inc (NEO) on Bullrun: market cap USD 2.15B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNEO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 2.15B
- Financial periodQ2 2026
- RevenueUSD 201.66M
- Net incomeUSD 2.24M
- Free cash flowUSD 11.74M
- Gross margin45.6%
Valuation Snapshot
latest market cap is USD 2.15B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 727.33M | -USD 108.00M | -USD 21.78M | 43.2% | -0.84 | USD 159.62M | USD 341.86M | USD 836.56M |
| FY2024 | USD 660.57M | -USD 79.00M | -USD 34.04M | 43.9% | -0.62 | USD 367.01M | USD 541.11M | USD 902.34M |
| FY2023 | USD 591.64M | -USD 88.00M | -USD 30.71M | 41.3% | -1.29 | USD 342.49M | USD 538.20M | USD 941.54M |
| FY2022 | USD 509.73M | -USD 144.00M | -USD 96.88M | 36.9% | n/a | USD 263.18M | USD 611.90M | USD 998.02M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 2.15B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.52B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 2.11B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.06B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 1.17B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 4.23B | n/a | n/a | n/a |
About Neogenomics Inc
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Neogenomics Inc's market cap?
Neogenomics Inc's market capitalization is USD 2.15B.
What does Neogenomics Inc do?
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories.